Trace elements, oxidative stress and glycemic control in young people with type 1 diabetes mellitus

Journal of Trace Elements in Medicine and Biology

Volumn 28, Issue 1, 2014, Pages 18-22

  Lin, Ching Chiang ^a,b   Huang, Hsiu Hua ^c   Hu, Chiung Wen ^d   Chen, Bai Hsiun ^e,f   Chong, Inn Wen ^f   Chao, Yu Ying ^g   Huang, Yeou Lih ^f,g  

^a FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

8 Hydroxy 2' deoxyguanosine; Copper; Malondialdehyde; Type 1 diabetes mellitus; Zinc

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; COPPER ION; HEMOGLOBIN A1C; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRACE ELEMENT; ZINC ION;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; COPPER BLOOD LEVEL; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CONCENTRATING CAPACITY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; URINE LEVEL; YOUNG ADULT; ZINC BLOOD LEVEL;

8-HYDROXY-2′-DEOXYGUANOSINE; COPPER; MALONDIALDEHYDE; TYPE 1 DIABETES MELLITUS; ZINC;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHILD; COPPER; DEOXYGUANOSINE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; TRACE ELEMENTS; YOUNG ADULT; ZINC;

EID: 84890875781     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2013.11.001     Document Type: Article

References (38)

1. Huebschmann A.G., Regensteiner J.G., Vlassara H., Reusch J.E.B. Diabetic and advanced glycoxidation end products. Diabetes Care 2006, 29(6):1420-1432.
2. Goodarzi M.T., Navidi A.A., Rezaei M., Babahmadi-Rezaei H. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes. J Clin Lab Anal 2010, 24(2):72-76.
3. Daneman D. Type 1 diabetes. Lancet 2006, 367(9515):847-858.
4. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17:24-38.
5. Pan H.Z., Zhang L., Guo M.Y., Sui H., Li H., Wu W.H., et al. The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol 2010, 47(Suppl. 1):71-76.
6. Chasapis C.T., Loutsidou A.C., Spiliopoulou C.A., Stefanidou M.E. Zinc and human health: an update. Arch Toxicol 2012, 86(4):521-534.
7. Malavolta M., Giacconi R., Piacenza F., Santarelli L., Cipriano C., Costarelli L., et al. Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population. Biogerontology 2010, 11(3):309-319.
8. Del Rio D., Stewart A.J., Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005, 15(4):316-328.
9. Martín-Gallán P., Carrascosa A., Gussinyé M., Domínguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003, 34(12):1563-1574.
10. Fathy S.A., El-Habashy S.A., Rasheed W.I., Helmy A.S., El-Saeed G.S.M., Said O.M., et al. Diagnostic potential of oxidative stress indicators in Egyptian type 1 diabetic children and adolescents. J Appl Sci Res 2009, 5(12):2524-2534.
11. Hoeldtke R.D., Bryner K.D., Hoeldtke M.E., Christie I., Ganser G., Hobbs G., et al. Sympathetic sudomotor disturbance in early type I diabetes mellitus is linked to lipid peroxidation. Metabolism 2006, 55(11):1524-1531.
12. Wu L.L., Chiou C.C., Chang P.Y., Wu J.T. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004, 339(1-2):11-25.
13. Cooke M.S., Olinski R., Evans M.D. Does measurement of oxidative damage to DNA have clinical significance?. Clin Chim Acta 2006, 365(1-2):30-49.
14. Hata I., Kaji M., Hirano S., Shigematsu Y., Tsukahara H., Mayumi M. Urinary oxidative stress markers in young patients with type 1 diabetes. Pediatr Int 2006, 48(1):58-61.
15. Klotz L.O., Kröncke K.D., Buchczyk D.P., Sies H. Role of copper, zinc, selenium and tellurium in the cellular defense against oxidative and nitrosative stress. J Nutr 2003, 133(7):1448-1451.
16. Lefebvre B., Vandewalle B., Balavoine A.S., Queniat G., Moerman E., Vantyghem M.C., et al. Regulation and functional effects of ZNT8 in human pancreatic islets. J Endocrinol 2012, 214(2):225-232.
17. Jansen J., Rosenkranz E., Overbeck S., Warmuth S., Mocchegiani E., Giacconi R., et al. Disturbed zinc homeostasis in diabetic patients by in vitro and in vivo analysis of insulinomimetic activity of zinc. J Nutr Biochem 2012, 23(11):1458-1466.
18. Viktorínová A., Toserová E., Krizko M., Duracková Z. Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism 2009, 58(10):1477-1482.
19. Suys B., de Beeck L.O., Rooman R., Kransfeld S., Heuten H., Goovaerts I., et al. Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase?. Pediatr Res 2007, 62(4):456-461.
20. The global IDF/ISPAD guideline for diabetes in childhood and adolescence (International Diabetes Federation). http://www.idf.org/global-idfispad-guideline-diabetes-childhood-and-adolescence.
21. Hu C.W., Wu M.T., Chao M.R., Pan C.H., Wang C.J., Swenberg J.A., et al. Comparison of analyses of urinary 8-hydroxy-2'-deoxyguanosine by isotope-dilution liquid chromatography with electrospray tandem mass spectrometry and by enzyme-linked immunosorbent assay. Rapid Commun Mass Spectrom 2004, 18(4):505-510.
22. Jayawardena R., Ranasinghe P., Galappatthy P., Malkanthi R., Constantine G., Katulanda P. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr 2012, 4(1):13.
23. Capdor J., Foster M., Petocz P., Samman S. Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans. J Trace Elem Med Biol 2013, 27(2):137-142.
24. Aguilar M.V., Saavedra P., Arrieta F.J., Mateos C.J., González M.J., Meseguer I., et al. Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome. Ann Nutr Metab 2007, 51(5):402-406.
25. Pedrosa L.F., Ferreira S.R., Cesarini P.R., Cozzolino S.M. Influence of glycemic control on zinc urinary excretion in patients with type 1 diabetes. Diabetes Care 1999, 22(2):362-363.
26. Nsonwu A.C., Usoro C.A.O., Etukudo M.H., Usoro I.N. Glycemic control and serum and urine levels of zinc and magnesium in diabetics in Calabar, Nigeria. Pak J Nutr 2006, 5(1):75-78.
27. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283(2-3):65-87.
28. Kawamura N., Ookawara T., Suzuki K., Konishi K., Mino M., Taniguchi N. Increased glycated Cu, Zn-superoxide dismutase levels in erythrocytes of patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1992, 74(6):1352-1354.
29. Ruiz C., Alegría A., Barberá R., Farré R., Lagarda M.J. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 1999, 59(2):99-105.
30. Hartnett M.E., Stratton R.D., Browne R.W., Rosner B.A., Lanham R.J., Armstrong D. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 2000, 23(2):234-240.
31. Erciyas F., Taneli F., Arslan B., Uslu Y. Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus. Arch Med Res 2004, 35(2):134-140.
32. Asicioglu E., Gogas Yavuz D., Koc M., Ozben B., Yazici D., Deyneli O., et al. Circulating endothelial cells are elevated in patients with type 1 diabetes mellitus. Eur J Endocrinol 2010, 162(4):711-717.
33. Cvetković T., Mitić B., Lazarević G., Vlahović P., Antić S., Stefanović V. Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy. J Diabetes Complications 2009, 23(5):337-342.
34. Chang J.M., Kuo M.C., Kuo H.T., Chiu Y.W., Chen H.C. Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy. J Lab Clin Med 2005, 146(4):210-215.
35. Xu G.W., Yao Q.H., Weng Q.F., Su B.L., Zhang X., Xiong J.H. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients. J Pharm Biomed Anal 2004, 36(1):101-104.
36. Nishikawa T., Sasahara T., Kiritoshi S., Sonoda K., Senokuchi T., Matsuo T., et al. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 2003, 26(5):1507-1512.
37. Tsukahara H., Sekine K., Uchiyama M., Kawakami H., Hata I., Todoroki Y., et al. Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes. Pediatr Res 2003, 54(3):419-424.
38. Hoeldtke R.D., Bryner K.D., Corum L.L., Hobbs G.R., Van Dyke K. Lipid peroxidation in early type 1 diabetes mellitus is unassociated with oxidative damage to DNA. Metabolism 2009, 58(5):731-734.